CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 22 filers reported holding CLOVIS ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 84,846,000 | $114,699,000 | 3.39% |
| SYMPHONY ASSET MANAGEMENT LLC | 6,000,000 | $8,104,000 | 0.82% |
| ZAZOVE ASSOCIATES LLC | 10,100,000 | $13,682,000 | 0.81% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 14,074,000 | $19,008,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 5,000,000 | $6,728,000 | 0.43% |
| CSS LLC/IL | 6,251,000 | $8,433,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 3,032,000 | $4,080,000 | 0.34% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,328,000 | $9,903,000 | 0.19% |
| Nicholas Investment Partners, LP | 1,620,000 | $2,180,000 | 0.07% |
| D. E. Shaw & Co., Inc. | 34,550,000 | $46,670,000 | 0.06% |